Repurposing Statin Drugs to Decrease Toxicity and Improve Survival Outcomes in Head and Neck Cancer

Objective The rising incidence of head and neck squamous cell carcinoma (HNSCC) calls for the assessment and improvement of currently available therapies that may enhance the therapeutic ratio in these patients. Statin drugs are one of the most widely used drug classes in the world for their lipid-l...

Full description

Bibliographic Details
Main Authors: Richard O. Bourguillon BS, William A. Stokes MD, Jennifer Dorth MD, Nicole C. Schmitt MD
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:OTO Open
Online Access:https://doi.org/10.1177/2473974X211065715